Jens De Vos

1.1k total citations
11 papers, 890 citations indexed

About

Jens De Vos is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Jens De Vos has authored 11 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Jens De Vos's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and HER2/EGFR in Cancer Research (3 papers). Jens De Vos is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and HER2/EGFR in Cancer Research (3 papers). Jens De Vos collaborates with scholars based in Belgium, Netherlands and United Arab Emirates. Jens De Vos's co-authors include Tony Lahoutte, Nick Devoogdt, Vicky Caveliers, Serge Muyldermans, Catarina Xavier, Sam Massa, Matthias D’Huyvetter, Sophie Hernot, Ilse Vaneycken and Geert Raes and has published in prestigious journals such as Journal of Clinical Oncology, Circulation Research and Scientific Reports.

In The Last Decade

Jens De Vos

11 papers receiving 873 citations

Peers

Countries citing papers authored by Jens De Vos

Since Specialization

Citations

This map shows the geographic impact of Jens De Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens De Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens De Vos more than expected).

Fields of papers citing papers by Jens De Vos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens De Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens De Vos. The network helps show where Jens De Vos may publish in the future.

Co-authorship network of co-authors of Jens De Vos

This figure shows the co-authorship network connecting the top 25 collaborators of Jens De Vos. A scholar is included among the top collaborators of Jens De Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens De Vos. Jens De Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Phase I Trial of ¹³¹I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients 2020 ·Journal of Nuclear Medicine ·Matthias D’Huyvetter, Jens De Vos, Vicky Caveliers, Ilse Vaneycken, Johannes Heemskerk, François P. Duhoux, Christel Fontaine, Marian Vanhoeij, Albert D. Windhorst, (unknown), N. Harry Hendrikse, Jos Eersels, Hendrik Everaert, (unknown), Nick Devoogdt, Geert Raes, Tony Lahoutte, Marleen Keyaerts	90
2	Phase I results of CAM-H2: Safety profile and tumor targeting in patients. 2018 ·Journal of Clinical Oncology ·Marleen Keyaerts, Jens De Vos, François P. Duhoux, Vicky Caveliers, Christel Fontaine, Marian Vanhoeij, Matthias D’Huyvetter, Hendrik Everaert, (unknown), Nick Devoogdt, Geert Raes, Tony Lahoutte	10
3	131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment 2017 ·Clinical Cancer Research ·Matthias D’Huyvetter, Jens De Vos, Catarina Xavier, Marek Pruszyński, Yann G.‐J. Sterckx, Sam Massa, Geert Raes, Vicky Caveliers, Michael R. Zalutsky, Tony Lahoutte, Nick Devoogdt	141
4	A nanobody-based tracer targeting DPP6 for non-invasive imaging of human pancreatic endocrine cells 2017 ·Scientific Reports ·Alexander Balhuizen, Sam Massa, (unknown), Jean‐Valéry Turatsinze, Jens De Vos, Stéphane Demine, Catarina Xavier, Olatz Villate, Isabelle Millard, Dominique Egrise, Carmen Capito, Raphaël Scharfmann, Pieter In 'T Veld, Piero Marchetti, Serge Muyldermans, Serge Goldman, Tony Lahoutte, Luc Bouwens, Décio L. Eizirik, Nick Devoogdt	40
5	Site-Specific Labeling of Cysteine-Tagged Camelid Single-Domain Antibody-Fragments for Use in Molecular Imaging 2014 ·Bioconjugate Chemistry ·Sam Massa, Catarina Xavier, Jens De Vos, Vicky Caveliers, Tony Lahoutte, Serge Muyldermans, Nick Devoogdt	149
6	Specific Targeting of Atherosclerotic Plaques in ApoE−/− Mice Using a New Camelid sdAb Binding the Vulnerable Plaque Marker LOX-1 2014 ·Molecular Imaging and Biology ·Jens De Vos, (unknown), Catarina Xavier, Sam Massa, U. Wernery, Luc Bouwens, Tony Lahoutte, Serge Muyldermans, Nick Devoogdt	23
7	Camelid single-domain antibody-fragment engineering for (pre)clinicalin vivomolecular imaging applications: adjusting the bullet to its target 2013 ·Expert Opinion on Biological Therapy ·Jens De Vos, Nick Devoogdt, Tony Lahoutte, Serge Muyldermans	109
8	Molecular Imaging Using Nanobodies: A Case Study 2012 ·Methods in molecular biology ·Nick Devoogdt, Catarina Xavier, Sophie Hernot, Ilse Vaneycken, Matthias D’Huyvetter, Jens De Vos, Sam Massa, Patrick De Baetselier, Vicky Caveliers, Tony Lahoutte	18
9	Site-Specific Labeling of His-Tagged Nanobodies with 99mTc: A Practical Guide 2012 ·Methods in molecular biology ·Catarina Xavier, Nick Devoogdt, Sophie Hernot, Ilse Vaneycken, Matthias D’Huyvetter, Jens De Vos, Sam Massa, Tony Lahoutte, Vicky Caveliers	44
10	Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions 2012 ·Circulation Research ·Alexis Broisat, Sophie Hernot, Jakub Toczek, Jens De Vos, Laurent Riou, Sandrine Martin, Mitra Ahmadi, Nicole M. Thielens, U. Wernery, Vicky Caveliers, Serge Muyldermans, Tony Lahoutte, Daniel Fagret, Cathérine Ghezzi, Nick Devoogdt	157
11	Immuno-imaging using nanobodies 2011 ·Current Opinion in Biotechnology ·Ilse Vaneycken, Matthias D’Huyvetter, Sophie Hernot, Jens De Vos, Catarina Xavier, Nick Devoogdt, Vicky Caveliers, Tony Lahoutte	109

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact